Company Analysis

TransMedics Group, Inc. (TMDX)

Nasdaq: TMDX · Electromedical & Electrotherapeutic Apparatus · Andover, MA · filing with the SEC since 2018
Grade7.2
◀ Past 7.1● Present 7.2▶ Future 7.1

Who runs TransMedics Group, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Hassanein Waleed H
President & CEO. First filing May 2019, latest Jul 14, 2026, 37 filings in all.
Officers reporting now
7
of 14 people with a filing in the last fifteen months
Directors reporting now
7
22 people on the record since 2019
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Araujo Fernando N.See RemarksSep 2026Oct 30, 2026none
Hassanein Waleed HPresident & CEOMay 2019Jul 14, 2026none
Hernandez GerardoChief Financial OfficerDec 2024Jul 14, 20264 · $1.2M
Corcoran NicholasSVP of Supply Chain and OperationsFeb 2023Jul 14, 20261 · $400,000
Forsyth Matthew S.Senior Vice President, General Counsel and SecretaryMar 2026May 21, 2026none
Ranganath Anil P.Senior Vice President, General Counsel and SecretaryJun 2023Mar 4, 20262 · $600,000
Cecere GiovanniChief Commercial OfficerFeb 2026Feb 20, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Tobin James RdirectorMay 2019Nov 12, 20262 · $400,000
Weill DaviddirectorMay 2019Sep 14, 20262 · $1.2M
Gunderson Thomas JamesdirectorMay 2019Jun 17, 20261 · $700,000
Basile Edward MdirectorMay 2019May 22, 2026none
Kania Edwin M JrdirectorMay 2019May 22, 2026none
Lovell StephaniedirectorMar 2021May 22, 20261 · $200,000
Raines MerileedirectorJan 2021May 22, 2026none
Earlier names on the record22, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton TMDX · research, not advice